Blockbusters for Cheap? The Difficulties Surrounding Generic Biologics

被引：1

|

作者：

Josephson, S. Andrew

Johnston, S. Claiborne

Hauser, Stephen L.

机构：

来源：

ANNALS OF NEUROLOGY | 2013年 / 74卷 / 03期

关键词：

D O I：

10.1002/ana.24023

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：A7 / A8

页数：2

相关论文

共 50 条

[1] The FDA and follow-on biologics - Navigating the issues surrounding biologics & likely outcome of FDA generic deliberation
Romza-Kutz, DJ
GENETIC ENGINEERING NEWS, 2006, 26 (06): : 8 - 9
[2] Niche drugs aren't a cheap alternative to blockbusters
W. Ross Tracey
Nature, 2007, 445 : 818 - 818
[3] Niche drugs aren't a cheap alternative to blockbusters
Tracey, W. Ross
NATURE, 2007, 445 (7130) : 818 - 818
[4] Generic biologics
Hess, Glenn
CHEMICAL & ENGINEERING NEWS, 2008, 86 (20) : 34 - 35
[5] Biologics in asthma: difficulties and drawbacks
Bousquet, Jean
Chiron, Raphael
Humbert, Marc
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (12) : 1921 - 1928
[6] Can biologics go generic?
Gill, Victoria
CHEMISTRY WORLD, 2008, 5 (03): : 20 - 23
[7] SENATE MOVES ON GENERIC BIOLOGICS
不详
CHEMICAL & ENGINEERING NEWS, 2009, 87 (29) : 32 - 32
[8] Abbreviated approval of generic biologics
Warren, William L.
Fang, Lei
Goran, Kristin
GENETIC ENGINEERING NEWS, 2006, 26 (21): : 9 - 10
[9] Entry and Competition in Generic Biologics
Grabowski, Henry G.
Ridley, David B.
Schulman, Kevin A.
MANAGERIAL AND DECISION ECONOMICS, 2007, 28 (4-5) : 439 - 451
[10] First generic biologics finally approved
Cormac Sheridan
Nature Reviews Drug Discovery, 2006, 5 (6) : 445 - 445

← 1 2 3 4 5 →